Professor pioneers spleen-targeted drug delivery system for lupus
Professor Tianfu Wu is developing a spleen-specific drug delivery system to suppress lupus-causing immune cells and reduce side effects.| Lupus News Today
Professor Tianfu Wu is developing a spleen-specific drug delivery system to suppress lupus-causing immune cells and reduce side effects.| Lupus News Today
Novartis' therapy candidate ianalumab safely and effectively eased disease activity for adults with active Sjögren's in two clinical trials.| Sjogren's Disease News
Being honest about lupus symptoms and challenges helps us be proactive and stay committed to our health, writes columnist Candace Semien.| Lupus News Today
Vor Bio signed an exclusive license agreement to develop and market Remegen’s telitacicept for MG outside China, Hong Kong, Macau, and Taiwan.| Myasthenia Gravis News
Among the many things columnist Candace Semien had to learn while living with lupus were the types and function of various needles.| Lupus News Today
NMOSD is among autoimmune disease risk factors, with patients at about nine times the risk of developing another condition, per a study.| Neuromyelitis News
While your journey may look different than others, you can still forge your own path with advocacy, columnist Marisa Zeppieri writes.| Lupus News Today
Antibodies targeting the TFAM protein could increase the risk of blood clotting complications in people with lupus, a study found.| Lupus News Today
May marks Lupus Awareness Month, and advocates will be joining together to bring attention to the disease to help "Make Lupus Visible."| Lupus News Today
The FDA has granted fast track status to ADI-001, Adicet Bio’s CAR T-cell therapy for treatment-resistant systemic lupus erythematosus (SLE).| Lupus News Today
